Herein, we highlighted a mechanism linking a CSCs maker DCLK1 and 5‐fluorouracil resistance, and demonstrated that DCLK1 inhibitor suppressed 5‐fluorouracil resistant CRC cells through inhibiting CCAR1/β‐catenin pathway‐mediated cancer stemness. This evidence concerns the gene CCAR1 and colorectal carcinoma.